The Clorox Company CLX
At closeNov 3, 2026, 6:30 PM EST
After hours · Nov 3, 6:30 PM ET
- YTD
- -6.97%
- 1 year
- -14.06%
- Market cap
- 11.34B
- Revenue (ttm)
- 6.72B
- Profit margin
- 8.73%
- EPS (ttm)
- 5.56
- Shares out
- 120.94M
- P/E ratio
- 16.87
- Forward P/E
- 15.30
- Dividend
- 5.00 (5.56%)
- Ex-dividend date
- Oct 27, 2026
- YTD return
- -6.97%
- 1-year return
- -14.06%
- Volume
- 4.14M
- Avg volume
- 2.90M
- Open
- 92.00
- Previous close
- 89.90
- Day's range
- 91.59 – 95.24
- 52-week range
- 79.12 – 128.90
- Beta
- 0.58
- Analysts
- Hold
- Price target
- 97.76 (+4.2%)
- Earnings date
- Feb 2, 2027
1Y -16.62 (-15.05%)
Key statistics
- Enterprise value
- 16.49B
- PEG ratio
- 1.13
- Price / sales
- 1.69
- Price / book
- 126.06
- Dividend yield
- 5.56%
- Payout ratio
- 103.12%
- Revenue growth
- -2.00%
- Free cash flow
- 110.38M
- Total cash
- 143.00M
- Total debt
- 5.60B
- Return on equity
- 163.76%
- Short % of float
- 9.78%
- 50-day average
- 88.26
- 200-day average
- 99.66
Analyst view
Consensus: hold
- Target (low)
- 74.00
- Target (mean)
- 97.76
- Target (high)
- 154.00
- Strong buy0
- Buy1
- Hold14
- Sell2
- Strong sell2
Next earnings
Feb 2, 2027
Expected Feb 2, 2027. Consensus EPS estimate 1.13.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 2, 2027 | Dec 30, 2026 | 1.36 | — | — | — |
| Nov 2, 2026 | Sep 30, 2026 | 1.07 | 1.55 | +0.48 | +44.86% |
| Aug 3, 2026 | Jun 30, 2026 | 1.64 | 1.66 | +0.02 | +1.22% |
| Apr 30, 2026 | Mar 31, 2026 | 1.55 | 1.64 | +0.09 | +5.81% |
| Feb 3, 2026 | Dec 31, 2025 | 1.43 | 1.39 | -0.04 | -2.80% |
| Nov 3, 2025 | Sep 30, 2025 | 0.818 | 0.85 | +0.03 | +3.91% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | JP Morgan | main | Underweight | Underweight |
| Nov 3, 2026 | UBS | main | Neutral | Neutral |
| Nov 3, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Nov 2, 2026 | Evercore ISI Group | up | Underperform | In-Line |
| Oct 19, 2026 | JP Morgan | main | Underweight | Underweight |
| Oct 16, 2026 | Barclays | main | Underweight | Underweight |
About The Clorox Company
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorinda, and Chux brands. It also provides bags and wraps, cat litter, and grilling products under the Glad, Fresh Step, Scoop Away, Kingsford, and Ever Clean brands; and dressings, dips, seasonings, sauces, water-filtration products, and natural personal care products under the Brita and Burt's Bees brands. The company sells its products through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; distributors; and other retail outlets through direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- United States
- Website
- thecloroxcompany.com
News
Clorox Now Expects Earnings Near the Low End of Its Forecast as Costs Rise. Should Dividend Investors Be Worried? 
Clorox Shares Rally After Q1 Earnings Beat 
JP Morgan Maintains Underweight on Clorox, Raises Price Target to $86 
Clorox Q1 Earnings Beat Estimates on Higher Sales & Cost Savings 
CLX Q1 Earnings Call Highlights Inflation and Margin Pressures 
Wells Fargo Maintains Equal-Weight on Clorox, Raises Price Target to $90 
Clorox Q1 Earnings Call Highlights 
The Clorox Company (CLX) Q1 2027 Earnings Call Transcript 
Compared to Estimates, Clorox (CLX) Q1 Earnings: A Look at Key Metrics 
Clorox (CLX) Surpasses Q1 Earnings and Revenue Estimates
Your note
Sign in to keep a note on CLX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARTON NINA | Officer | Stock Award(Grant) | Sep 15, 2025 | 28,496 |
| BELLET LUC | Chief Financial Officer | Stock Award(Grant) | Oct 4, 2026 | 74,860 |
| BREBER PIERRE R. | Director | Purchase | May 4, 2026 | 0 |
| GRIER STACEY | Officer | Stock Award(Grant) | Oct 2, 2025 | 32,203 |
| HILT ANGELA CHRISTINE | Officer | Stock Award(Grant) | Oct 4, 2026 | 70,436 |
| HYDER CHRIS T | Chief Operating Officer | Stock Award(Grant) | Oct 4, 2026 | 92,986 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.31% | 10,044,423 | 942.07M | Jun 29, 2026 |
| State Street Corporation | 6.97% | 8,432,523 | 790.89M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.53% | 7,896,390 | 740.60M | Jun 29, 2026 |
| Invesco Ltd. | 4.97% | 6,010,072 | 563.68M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.80% | 5,799,952 | 543.98M | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.70% | 3,265,551 | 306.28M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.18% | 3,841,610 | 360.30M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 3,134,905 | 294.02M | Jun 29, 2026 |
| VanEck ETF Trust-VanEck Morningstar Wide Moat ETF | 2.50% | 3,018,299 | 283.09M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 2,771,626 | 259.95M | Jun 29, 2026 |
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | 1.80% | 2,182,632 | 204.71M | Sep 29, 2026 |
| AIM Sector Funds (Invesco Sector Funds)-INVESCO COMSTOCK FUND | 1.49% | 1,806,888 | 169.47M | Jul 30, 2026 |